openPR Logo
Press release

Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic Bacterial Infection

09-04-2018 08:13 AM CET | Health & Medicine

Press release from: Transparency Market Research

Bacterial Conjunctivitis Drugs Market Driven by Rising

The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can be predicted between small biotech research organizations and bigger pharmaceutical firms. This could prove to be successful strategy in the U.S. bacterial conjunctivitis drugs market.

According to Transparency Market Research, the U.S. bacterial conjunctivitis drugs market will be worth US$439.8 mn by 2024. This will be a decrease from the previous years as the generic variants encroach the market of bacterial conjunctivitis drugs. On the basis of drug class, the topical fluoroquinolones segment is leading in terms of demand.

Obtain Report Details @ https://www.transparencymarketresearch.com/us-bacterial-conjunctivitis-drugs-market.html

However, the demand for topical fluoroquinolones will reduce drastically on account of patent expirations of best selling drugs of this class, including, Moxeza, Vigamox, and Zymaxid. This market segment’s worth is estimated to come down to US$286.4 mn by 2024 on account of encroachment by generic variations of these drugs.

Availability of Affordable Generic Medications to Dampen Growth of Bacterial Conjunctivitis Drugs Market

The report states that the U.S. bacterial conjunctivitis drugs market is likely to experience a patent cliff in the near future. The availability of cost effective generic medicines will hamper the market for bacterial conjunctivitis drugs extensively. There is a dearth of novel compounds available for clinical and preclinical examination. There are very few investigations regarding bacterial conjunctivitis and approval of drugs in the pipeline at present. In addition to this, owing to drug expiry issue, doctors are prescribing a variety of affordable generic medications from the past few years.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12323

Ophthalmologists and optometrists generally prescribe antibiotics in the form of eye drops and ointments. All these factors are behind the decline of the U.S. bacterial conjunctivitis drugs market. In addition to all these, patients are aware that conjunctivitis is usually acute and will cure on its own in a few days, limiting the demand for bacterial conjunctivitis drugs.

Herbal Treatment May Prove Profitable

On a positive note however, the shift from pharmacological medicines to herbal treatment options will open doors for growth opportunities in the market. Manufacturers are recommended to develop herbal products for the treatment of bacterial conjunctivitis to earn profit. The growing prevalence of ophthalmic bacterial infection will also help the market’s growth. In addition to this, the susceptibility of this infection to spread among all age groups from infants to the elderly will drive the growth prospects for this market in the U.S.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12323

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic Bacterial Infection here

News-ID: 1217835 • Views:

More Releases from Transparency Market Research

Breast Tape Market Growth and Restrain Factors Analysis 2034
Breast Tape Market Growth and Restrain Factors Analysis 2034
The breast tape market (рынок лент для груди) has emerged as a significant segment within the fashion and personal care industries. Breast tapes, also known as tapes or body tapes, provide support and shaping solutions, allowing users to wear various outfits without the need for traditional bras. They are particularly popular for their ability to create a seamless and natural look under different types of clothing. The market is driven
Smart Planter Market Current Scenario and Future Growth Analysis by 2034 || GAOBI, LetPot's, Yoolax
Smart Planter Market Current Scenario and Future Growth Analysis by 2034 || GAOB …
The smart planter market (mercato delle fioriere intelligenti), an intersection of technology and agriculture, involves planters equipped with sensors and automated systems to optimize plant growth. These devices monitor soil moisture, nutrient levels, and environmental conditions, providing data to enhance agricultural productivity. As precision agriculture and smart farming gain traction, the smart planter market is poised for significant growth over the next decade. Market Size and Growth The smart planter market (Markt
Dog Treat Launcher Market Share and Growth Factors Impact Analysis 2034 || Furhaven Pet Products, Petz Planet
Dog Treat Launcher Market Share and Growth Factors Impact Analysis 2034 || Furha …
The dog treat launcher market, a niche yet innovative segment within the broader pet products industry, has seen considerable growth in recent years. Dog treat launchers are devices designed to dispense treats to dogs in an engaging and interactive manner. They cater to pet owners seeking to provide physical and mental stimulation for their pets, contributing to the overall well-being of dogs. As the pet ownership trend continues to rise
Dive Slate Market Current Trends and Future Aspect Analysis 2034 || AQUATEC - DUTON INDUSTRY CO., LTD.
Dive Slate Market Current Trends and Future Aspect Analysis 2034 || AQUATEC - DU …
Dive slates(Tauchtafeln) are essential tools for divers, providing a waterproof writing surface for underwater communication, note-taking, and data recording. As the popularity of recreational and professional diving continues to grow, the dive slate market is expected to see significant developments over the next decade. Market Size and Growth The dive slate market(Mercato delle liste per immersion) is projected to experience steady growth from 2024 to 2034, driven by increased interest in underwater

All 5 Releases


More Releases for Bacterial

Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills. Read Report Overview -
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Vaginosis Drug Market is Growing Rapidly Due To Rising Awareness About …
Worldwide Market Reports added Latest Research Report titled "Global Bacterial Vaginosis Drug Market by Manufacturers, Regions, Product Type and Application, Forecast to 2022" to its Large Report database. In this report, the global Bacterial Vaginosis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Ask For Sample Copy
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
12-06-2016 | Health & Medicine
SA-BRC
Hospital and Community Acquired Bacterial Infections Pushing Growth of Anti-Bact …
This report covers the market for major anti-bacterial drugs marketed today along with a pipeline analysis and takes the reader through 22 major drugs expected to be seen in the period between 2013 and 2019. The report analyzes marketed and approved drugs such as Cubicin, Teflaro/Zinforo, Dificid, Dalvance, Orbactiv, Sivextro, Zerbaxa, Avycaz, Zyvox, Avelox, Augmentin, Zosyn/Tazocin, Invanz and Tygacil. Along with this, it also reports analysis for other expected candidates